超声乳腺分期联合内分泌激素参考值检测女性青春期启动
该横断面研究纳入601名6至16岁健康挪威女孩,整合超声乳腺分期与下丘脑-垂体-性腺激素参考值,并评估内分泌谱对判断乳房发育启动的预测价值。基于主成分分析的内分泌谱指数判断青春期启动的ROC曲线下面积为0.91(P < 0.001),优于年龄或任一单独激素。临床青春期前表现但超声检出不可触及腺体组织的女孩,其雌二醇中位数显著更高。
要点
- 建立与年龄、Tanner分期及超声乳腺分期对应的E2、E1、LH、FSH、SHBG参考值。
- 内分泌谱指数判断青春期启动的AUC为0.91(P < 0.001),优于年龄或单一激素。
- 临床青春期前但超声见腺体组织者,雌二醇中位数12.5 vs 4.9 pmol/L(P < 0.05)。
核心结论
- 首次提供与超声乳腺分期配套的激素参考值,并证明内分泌谱可改善女性青春期启动的检测。
研究设计与样本
- 横断面研究,纳入601名6至16岁健康挪威女孩。
- 所有受试者均进行临床与超声乳腺评估。
- 血样采用免疫分析及超灵敏液相色谱-串联质谱(LC-MS/MS)定量E2和E1至亚皮摩尔范围。
主要发现
- 构建了E2、E1、LH、FSH、SHBG相对于实足年龄、Tanner分期和超声乳腺分期的参考值。
- 基于上述指标主成分分析的内分泌谱指数判断青春期启动的ROC曲线下面积为0.91(P < 0.001)。
- 临床青春期前表现女孩中,264例有14例(5.3%)超声检出不可触及腺体组织,其雌二醇中位数显著更高(12.5 vs 4.9 pmol/L;P < 0.05)。
- 超声检出腺体组织者具有独特的内分泌谱(任意单位;P < 0.001)。
关键数值与推荐
- 内分泌谱指数判断青春期启动的ROC曲线下面积为0.91(P < 0.001)。
- 临床青春期前但超声见腺体组织者雌二醇中位数12.5 vs 4.9 pmol/L(P < 0.05)。
临床怎么用
- 可将超声乳腺分期与配套激素参考值结合用于评估女性青春期启动与进展。
- 对临床青春期前表现者,超声检出不可触及腺体组织提示内分泌活动已启动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Application of ultrasound (US) to evaluate attainment and morphology of glandular tissue provides a new rationale for evaluating onset and progression of female puberty, but currently no hormone references complement this method. Furthermore, previous studies have not explored the predictive value of endocrine profiling to determine female puberty onset. OBJECTIVE: To integrate US breast staging with hypothalamic-pituitary-gonadal hormone references and test the predictive value of an endocrine profile to determine thelarche. DESIGN SETTING AND PARTICIPANTS: Cross-sectional sample of 601 healthy Norwegian girls, ages 6 to 16 years. MAIN OUTCOME MEASURES: Clinical and ultrasound breast evaluations were performed for all included girls. Blood samples were analyzed by immunoassay and ultrasensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) to quantify estradiol (E2) and estrone (E1) from the subpicomolar range. RESULTS: References for E2, E1, luteinizing hormone, follicle-stimulating hormone, and sex hormone-binding globulin were constructed in relation to chronological age, Tanner stages, and US breast stages. An endocrine profile index score derived from principal component analysis of these analytes was a better marker of puberty onset than age or any individual hormone, with receiver-operating characteristic area under the curve 0.91 (P < 0.001). Ultrasound detection of nonpalpable glandular tissue in 14 out of 264 (5.3%) girls with clinically prepubertal presentation was associated with significantly higher median serum levels of E2 (12.5 vs 4.9 pmol/L; P < 0.05) and a distinct endocrine profile (arbitrary units; P < 0.001). CONCLUSIONS: We provide the first hormone references for use with US breast staging and demonstrate the application of endocrine profiling to improve detection of female puberty onset.
引用
- Madsen A, Bruserud IS, Bertelsen BE, et al. Hormone References for Ultrasound Breast Staging and Endocrine Profiling to Detect Female Onset of Puberty. J Clin Endocrinol Metab. 2020. PMID: 32961560. doi:10.1210/clinem/dgaa679
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。